BridgeMD
Tests treatment safety and results for Coronary Artery Disease
Official title Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small Vessels
ClinicalTrials.gov ID: NCT07410364
What this study is testing
- What it's testing
- Randomized controlled trial of adaptive design for the safety and efficacy of coronary angiography and percutaneous coronary intervention via distal transradial access using a 6-French Glidesheath Slender in patients with small vessels.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Age between 18 and 85 years
- Palpable pulses in both the distal radial artery and conventional radial artery
- All patients signed informed consent forms prior to procedure
You likely can't join if
- Ultrasound assessment of the distal radial artery diameter ≥2.0mm or \<1.0mm
- Height ≥185.0cm
- Patients with acute ST-segment elevation myocardial infarction, cardiogenic shock, or hemodynamic instability
- Contraindications for puncture of the distal radial artery
- Patients with Raynaud's syndrome
- Patients with coagulation disorders or hematologic diseases
See the full eligibility criteria
- Age between 18 and 85 years
- Palpable pulses in both the distal radial artery and conventional radial artery
- All patients signed informed consent forms prior to procedure
- Ultrasound assessment of the distal radial artery diameter ≥2.0mm or \<1.0mm
- Height ≥185.0cm
- Patients with acute ST-segment elevation myocardial infarction, cardiogenic shock, or hemodynamic instability
- Contraindications for puncture of the distal radial artery
- Patients with Raynaud's syndrome
- Patients with coagulation disorders or hematologic diseases
- Patients currently enrolled in other clinical studies
The study team makes the final eligibility decision.
Where it's taking place
- Changzhou, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changzhou, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.